Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. reports developments tied to its national home health and hospice care business in the United States. The company’s Home Health segment provides Medicare-certified nursing, therapy, medical social work and aide services for adult patients, while its Hospice segment focuses on care for patients with life-limiting illnesses.
Recurring Enhabit news includes quarterly operating results, home health admissions and census trends, hospice performance, debt reduction and credit-related actions, investor presentations, material agreements, shareholder voting matters and governance updates. Company updates also cover legal and regulatory disclosures when they affect its public-company reporting or corporate matters.
Enhabit, a top home health and hospice provider, has shared an investor presentation ahead of its 2024 Annual Meeting on July 25. The company has shown improved performance, with a 5.3% increase in Home Health admissions and 5.6% growth in Hospice admissions. Non-Medicare admissions rose 25%, and payor innovation contracts now cover 38% of non-Medicare visits. Enhabit has added 151 full-time nurses. The Board, refreshed since the spin-off from Encompass Health, emphasizes its strategic initiatives and opposes AREX Capital's attempt to take control, citing it would disrupt business stability. Stockholders are urged to vote for Enhabit's nominees via the YELLOW proxy card.
AREX Capital Management, LP, which owns 4.9% of Enhabit’s outstanding common shares, has released a presentation outlining a comprehensive plan to improve Enhabit’s operational performance.
The plan includes recapturing home health market share, revamping hospice sales, and reducing corporate overhead, with an anticipated 50% increase in EBITDA. AREX is urging stockholders to vote for its seven nominees using the WHITE Proxy Card at the 2024 Annual Meeting.
AREX believes their nominees possess the necessary experience and skills to oversee management and drive significant value creation for Enhabit’s stockholders.
Further details are available at www.RehabEHAB.com.
Enhabit (NYSE: EHAB), a key player in home health and hospice care, has outlined steps to stabilize its business and drive profitable growth following its separation from Encompass Health The company's letter to shareholders addresses misstatements by AREX Capital Management, which seeks to replace the Board of Directors. Enhabit emphasizes its progress in stabilizing the business, improving Medicare Advantage contract rates, and enhancing its hospice business. The letter urges shareholders to vote for Enhabit's Board nominees on the YELLOW proxy card at the upcoming annual meeting on July 25, 2024.
AREX Capital Management, owning 4.9% of Enhabit’s shares (NYSE: EHAB), has issued a letter urging stockholders to support its nominees on the WHITE proxy card in the 2024 Annual Meeting. AREX criticizes Enhabit's financial and operational performance and emphasizes the need for new leadership to navigate the challenging market. AREX believes their nominees are best positioned to rehabilitate the company and ensure effective oversight and accountability to stockholders.
Enhabit, a leading national home health and hospice provider, has been recognized by U.S. News & World Report as one of the Best Companies to Work For in the South for 2024-2025. This accolade underscores Enhabit's commitment to fostering a supportive work environment that emphasizes work-life balance, professional development, and employee recognition. The company, which employs over 10,000 people, offers flexible schedules, competitive compensation, and advanced technology to aid in delivering high-quality care. Chief Human Resources Officer Tanya Marion highlighted the company's focus on valuing each team member's role and investing in their personal and professional growth. Enhabit operates 255 home health locations and 112 hospice locations across 34 states.
Enhabit (NYSE: EHAB) has filed definitive proxy materials with the SEC for its 2024 Annual Meeting scheduled on July 25, 2024. Shareholders as of June 5, 2024, are entitled to vote. Enhabit, a home health and hospice provider, urges shareholders to vote for its nine board nominees via the YELLOW proxy card, arguing that AREX Capital Management's nominated slate lacks the necessary experience and stability. Enhabit has faced financial and operational challenges since its 2022 spin-off from Encompass Health. However, it has undertaken several initiatives to stabilize and position the company for growth, including improving Medicare Advantage rates, securing new payor agreements, and increasing full-time nursing staff. Enhabit’s board emphasizes its qualifications and experience in navigating industry headwinds and executing strategic plans, while criticizing AREX’s proposed changes as potentially destabilizing. The company aims to leverage its recent stability to drive future growth in home health and hospice care.
Enhabit (NYSE: EHAB) filed its preliminary proxy materials with the SEC for its 2024 annual meeting. This step follows a nine-month strategic review process, influenced by AREX Capital Management's push for the company’s sale. Despite efforts involving 38 potential counterparties, no formal offers were received. Challenges included regulatory changes, high interest rates, and the healthcare operating environment. The Board engaged fully in the review but decided to terminate the process without actionable proposals.
Enhabit, a leading national home health and hospice provider, announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. The event will feature Enhabit’s President and CEO, Barbara Jacobsmeyer, along with CFO Crissy Carlisle. They will engage in a fireside chat on June 11 at 10 a.m. EDT, which will be webcast live and available for replay.
Enhabit supports patients and families across 255 home health and 112 hospice locations in 34 states, leveraging advanced technology and compassionate care teams. For more details, visit ehab.com.
Enhabit (NYSE: EHAB), a national provider of home health and hospice services, will participate in the Leerink Partners Healthcare Crossroads Conference 2024.
Company executives, President and CEO Barbara Jacobsmeyer and CFO Crissy Carlisle, will engage in a fireside chat on May 29 at 10 a.m. CDT. The event will be webcast live with a replay available on the company's investor relations website.
Enhabit operates 255 home health locations and 112 hospice locations across 34 states, utilizing advanced technology and compassionate care to enhance patient outcomes.
Enhabit, Inc. (NYSE: EHAB) has concluded its strategic review process and decided to continue operating independently as a public company. The Board determined that it is in the best interest of the Company and its shareholders to follow this path, after evaluating various strategic alternatives, including a potential sale or merger. Despite interest from potential partners, no formal proposals for a transaction were received. The Company attributes the lack of transaction to macro headwinds, regulatory developments, and a challenging operating environment. The management team is now focused on executing the Company's operating plan to enhance shareholder value.